e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Respiratory medicine meets rheumatology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Undifferentiated systemic rheumatic diseases and overlap syndromes: when can we diagnose interstitial pneumonia with autoimmune features (IPAF)?
K. Antoniou (Heraklion, Greece)
Source:
International Congress 2018 – Respiratory medicine meets rheumatology
Session:
Respiratory medicine meets rheumatology
Session type:
Symposium
Number:
5141
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Antoniou (Heraklion, Greece). Undifferentiated systemic rheumatic diseases and overlap syndromes: when can we diagnose interstitial pneumonia with autoimmune features (IPAF)?. International Congress 2018 – Respiratory medicine meets rheumatology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Interstitial pneumonia with autoimmune features (IPAF): a clinical entity?
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011
Impact of comorbidities in interstitial pneumonia with autoimmune features (IPAF)
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Idiopathic non-specific interstitial pneumonia (NSIP): is it an autoimmune clinical entity?
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Characterisation of patients with interstitial pneumonia with autoimmune features
Source: Eur Respir J 2016; 47:1767-1775
Year: 2016
Interstitial pneumonia with autoimmune features: a new classification still on the move
Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018
Year: 2018
Interstitial pneumonia with autoimmune features
Source: Guideline 2015
Year: 2015
Interstitial pneumonia with autoimmune features
Source: Eur Respir Monogr 2019; 86: 140-152
Year: 2019
Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011
Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)
Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017
Year: 2018
Bronchiectasis and autoimmune disease
Source: Eur Respir Mon 2011; 52: 192-210
Year: 2011
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Lymphoid interstitial pneumonia should be suspected in children with autoimmune disease and immune deficiency
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
COPD: an autoimmune disease?
Source: Eur Respir J 2011; 38: 484
Year: 2011
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept